Precision BioSciences Inc.

Last updated September 27, 2026

Organization details

Legal name
Precision BioSciences Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Durham
Headquarters state / province
North Carolina
Headquarters country
United States
Fiscal year end
May
Ticker symbol
DTIL
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001357874

Board of directors

Chief executives

Michael Amoroso · President and CEO
Dates unknown

Director election results

Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 4 other boards. 4 are in the same sector.

Network of Precision BioSciences Inc.'s board connections Abeona Therapeutics Inc. Abeona Therapeutics In... Eloxx Pharmaceuticals Inc. Eloxx Pharmaceuticals... Entera Bio Ltd. Entera Bio Ltd. Harmony Biosciences Holdings Inc. Harmony Biosciences Ho... Geno J. Germano Geno J. Germano Michael Amoroso Michael Amoroso Precision BioSciences Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$63,215
6 purchases by 3 insiders
Sold, last 12 months
$431,271
8 sales by 4 insiders
Date Insider Transaction Shares Price Value
Sep 28, 2026 Stanley Frankel Director Open-market purchase +1,000 $6.00 $6,000
Sep 25, 2026 Melinda Brown Director Open-market purchase +1,135 $6.27 $7,116
Sep 25, 2026 Geno J. Germano Director Open-market purchase +2,609 $6.28 $16,385
May 20, 2026 Kevin Buehler Director Option exercise +21,000 — —
May 20, 2026 Stanley Frankel Director Option exercise +21,000 — —
May 20, 2026 Melinda Brown Director Option exercise +21,000 — —
May 20, 2026 Shari Lisa Pire Director Option exercise +21,000 — —
May 20, 2026 Geno J. Germano Director Option exercise +21,000 — —
Feb 18, 2026 Michael Amoroso Director, Officer (President and CEO) Open-market sale −20,559 $3.84 $78,947
Feb 18, 2026 Kelly John Alexander Officer (Chief Financial Officer) Open-market sale −8,149 $3.84 $31,292
Feb 18, 2026 Scimeca Dario Officer (General Counsel and Secretary) Open-market sale −4,925 $3.84 $18,912
Feb 18, 2026 SMITH J. JEFFERSON Officer (Chief Research Officer) Open-market sale −4,925 $3.84 $18,912
Feb 17, 2026 Michael Amoroso Director, Officer (President and CEO) Option exercise +67,797 — —
Feb 17, 2026 Kelly John Alexander Officer (Chief Financial Officer) Option exercise +27,584 — —
Feb 17, 2026 Scimeca Dario Officer (General Counsel and Secretary) Option exercise +16,667 — —

Organizations in the same sector, closest in location and size first.

Questions about Precision BioSciences Inc.

Who is the CEO of Precision BioSciences Inc.?

Michael Amoroso is Precision BioSciences Inc.'s President and CEO.

How many directors are on Precision BioSciences Inc.'s board?

Precision BioSciences Inc.'s board has 7 directors: Geno J. Germano, Kevin Buehler, Melinda Brown, Michael Amoroso, Samuel C. Wadsworth, Shari Lisa Pire and Stanley Frankel.

Are Precision BioSciences Inc. insiders buying or selling shares?

Over the last 12 months, Precision BioSciences Inc. insiders bought $63,215 of shares in 6 purchases and sold $431,271 of shares in 8 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="precision-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.